Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetic Nephropathies | 24 | 2021 | 983 | 4.440 |
Why?
|
Glucosephosphate Dehydrogenase | 20 | 2019 | 207 | 4.160 |
Why?
|
Endocrinology | 19 | 2023 | 443 | 2.660 |
Why?
|
Diabetes Mellitus | 24 | 2023 | 5724 | 1.670 |
Why?
|
NADP | 8 | 2017 | 225 | 1.340 |
Why?
|
Albuminuria | 7 | 2018 | 683 | 1.080 |
Why?
|
Renal Insufficiency, Chronic | 6 | 2023 | 2195 | 1.060 |
Why?
|
Acidosis, Lactic | 2 | 2015 | 142 | 0.950 |
Why?
|
Standard of Care | 23 | 2023 | 562 | 0.950 |
Why?
|
Oxidative Stress | 10 | 2018 | 3081 | 0.880 |
Why?
|
Hyperglycemia | 6 | 2021 | 1368 | 0.830 |
Why?
|
Hypoglycemic Agents | 5 | 2023 | 2866 | 0.800 |
Why?
|
Kidney | 15 | 2021 | 7167 | 0.800 |
Why?
|
Reference Standards | 19 | 2023 | 1020 | 0.800 |
Why?
|
Isoproterenol | 1 | 2021 | 399 | 0.790 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2021 | 202 | 0.750 |
Why?
|
Athletic Performance | 2 | 2020 | 95 | 0.720 |
Why?
|
Pentose Phosphate Pathway | 7 | 2018 | 124 | 0.650 |
Why?
|
Lactates | 1 | 2019 | 432 | 0.640 |
Why?
|
Metformin | 2 | 2015 | 829 | 0.640 |
Why?
|
Diabetes Mellitus, Type 1 | 10 | 2023 | 3336 | 0.640 |
Why?
|
Diabetes Mellitus, Experimental | 4 | 2018 | 1121 | 0.570 |
Why?
|
Glucose | 8 | 2021 | 4391 | 0.570 |
Why?
|
Diabetes Mellitus, Type 2 | 11 | 2023 | 11695 | 0.540 |
Why?
|
Glomerular Filtration Rate | 8 | 2017 | 2167 | 0.510 |
Why?
|
Thigh | 1 | 2016 | 247 | 0.510 |
Why?
|
Sodium-Glucose Transporter 2 | 2 | 2017 | 85 | 0.500 |
Why?
|
Medical Audit | 1 | 2016 | 467 | 0.500 |
Why?
|
Glucosephosphate Dehydrogenase Deficiency | 2 | 2017 | 89 | 0.480 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2018 | 292 | 0.480 |
Why?
|
Societies, Medical | 19 | 2023 | 3740 | 0.450 |
Why?
|
Oligonucleotides, Antisense | 4 | 2012 | 433 | 0.430 |
Why?
|
Oligonucleotides | 2 | 2012 | 572 | 0.430 |
Why?
|
Exercise Test | 2 | 2016 | 2075 | 0.420 |
Why?
|
Glycosuria, Renal | 1 | 2011 | 4 | 0.410 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 4 | 2012 | 491 | 0.370 |
Why?
|
Glucosides | 1 | 2013 | 446 | 0.360 |
Why?
|
Blood Pressure | 6 | 2018 | 8541 | 0.350 |
Why?
|
Microscopy, Fluorescence | 1 | 2015 | 2699 | 0.320 |
Why?
|
Monitoring, Physiologic | 1 | 2015 | 1737 | 0.310 |
Why?
|
Kidney Diseases | 2 | 2017 | 2145 | 0.300 |
Why?
|
Benzhydryl Compounds | 1 | 2013 | 840 | 0.300 |
Why?
|
Oxygen | 1 | 2019 | 4169 | 0.300 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2013 | 923 | 0.300 |
Why?
|
Kidney Failure, Chronic | 6 | 2017 | 2536 | 0.290 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2013 | 1517 | 0.280 |
Why?
|
Nitric Oxide | 6 | 2017 | 2128 | 0.280 |
Why?
|
Luminescent Proteins | 2 | 2021 | 853 | 0.270 |
Why?
|
Reactive Oxygen Species | 8 | 2019 | 2077 | 0.260 |
Why?
|
Mitochondria | 4 | 2021 | 3520 | 0.250 |
Why?
|
Antioxidants | 4 | 2012 | 1659 | 0.250 |
Why?
|
Mental Health Services | 1 | 2016 | 1643 | 0.250 |
Why?
|
Cell Survival | 2 | 2012 | 5872 | 0.250 |
Why?
|
Podocytes | 2 | 2019 | 394 | 0.240 |
Why?
|
Hemodynamics | 2 | 2013 | 4197 | 0.230 |
Why?
|
Humans | 67 | 2023 | 742088 | 0.230 |
Why?
|
Animals | 36 | 2019 | 168561 | 0.230 |
Why?
|
Renin-Angiotensin System | 2 | 2021 | 759 | 0.220 |
Why?
|
Blood Glucose | 4 | 2018 | 6249 | 0.210 |
Why?
|
Insulin-Secreting Cells | 1 | 2009 | 891 | 0.210 |
Why?
|
Cell Death | 3 | 2014 | 1695 | 0.210 |
Why?
|
Glycolysis | 4 | 2019 | 825 | 0.210 |
Why?
|
Mentors | 1 | 2007 | 630 | 0.210 |
Why?
|
Cyclic AMP | 3 | 2007 | 1470 | 0.200 |
Why?
|
Losartan | 1 | 2003 | 298 | 0.200 |
Why?
|
Rats | 12 | 2019 | 24265 | 0.190 |
Why?
|
Catalase | 2 | 2018 | 222 | 0.190 |
Why?
|
Hypertension | 2 | 2015 | 8455 | 0.190 |
Why?
|
Basketball | 1 | 2020 | 49 | 0.190 |
Why?
|
Schools, Medical | 1 | 2007 | 878 | 0.180 |
Why?
|
Platelet-Derived Growth Factor | 2 | 1994 | 625 | 0.180 |
Why?
|
Proteinuria | 2 | 2014 | 657 | 0.180 |
Why?
|
Endothelial Cells | 1 | 2012 | 3455 | 0.180 |
Why?
|
Cattle | 7 | 2012 | 3923 | 0.170 |
Why?
|
Thymidine | 3 | 2012 | 309 | 0.170 |
Why?
|
Mental Disorders | 2 | 2016 | 6587 | 0.170 |
Why?
|
Interleukin-1 | 1 | 2002 | 1262 | 0.170 |
Why?
|
Tumor Cells, Cultured | 3 | 2002 | 6313 | 0.160 |
Why?
|
Oxidation-Reduction | 5 | 2014 | 2187 | 0.160 |
Why?
|
Program Evaluation | 1 | 2007 | 2485 | 0.160 |
Why?
|
RNA, Small Interfering | 2 | 2021 | 3504 | 0.160 |
Why?
|
Endothelium, Vascular | 5 | 2007 | 4455 | 0.160 |
Why?
|
Education, Medical, Undergraduate | 1 | 2007 | 1004 | 0.160 |
Why?
|
Kallikrein-Kinin System | 1 | 2017 | 9 | 0.160 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2021 | 1723 | 0.160 |
Why?
|
Kidney Cortex | 2 | 2009 | 186 | 0.150 |
Why?
|
Genes, Reporter | 1 | 2021 | 1547 | 0.150 |
Why?
|
Oxidative Phosphorylation | 1 | 2019 | 480 | 0.150 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2023 | 700 | 0.150 |
Why?
|
Islets of Langerhans | 1 | 2023 | 1351 | 0.150 |
Why?
|
Epidermal Growth Factor | 2 | 1991 | 709 | 0.140 |
Why?
|
Mice | 14 | 2019 | 81045 | 0.140 |
Why?
|
Patient-Centered Care | 1 | 2007 | 1436 | 0.140 |
Why?
|
NAD | 1 | 2000 | 594 | 0.140 |
Why?
|
Retinal Diseases | 1 | 2023 | 683 | 0.140 |
Why?
|
Creatinine | 6 | 2017 | 1916 | 0.140 |
Why?
|
Coagulants | 1 | 2016 | 49 | 0.140 |
Why?
|
Transfection | 5 | 2012 | 5892 | 0.140 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2017 | 297 | 0.140 |
Why?
|
Energy Metabolism | 2 | 2019 | 2896 | 0.130 |
Why?
|
Superoxide Dismutase | 1 | 2018 | 596 | 0.130 |
Why?
|
Pyruvate Kinase | 1 | 2017 | 189 | 0.130 |
Why?
|
Kallikreins | 1 | 2016 | 258 | 0.130 |
Why?
|
HEK293 Cells | 2 | 2021 | 4200 | 0.130 |
Why?
|
Paraquat | 1 | 2014 | 32 | 0.120 |
Why?
|
Ubiquitination | 1 | 2019 | 1011 | 0.120 |
Why?
|
Endpoint Determination | 1 | 2017 | 600 | 0.120 |
Why?
|
Cystatin C | 2 | 2012 | 250 | 0.120 |
Why?
|
Students, Medical | 1 | 2007 | 1858 | 0.120 |
Why?
|
Antihypertensive Agents | 1 | 2003 | 2043 | 0.120 |
Why?
|
Enzyme Activation | 3 | 2012 | 3701 | 0.120 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 12071 | 0.120 |
Why?
|
Dimerization | 1 | 2015 | 893 | 0.120 |
Why?
|
Receptors, Platelet-Derived Growth Factor | 1 | 1994 | 180 | 0.120 |
Why?
|
Aorta | 2 | 2001 | 2057 | 0.120 |
Why?
|
History, 21st Century | 1 | 2019 | 1533 | 0.110 |
Why?
|
Male | 28 | 2020 | 349538 | 0.110 |
Why?
|
Cell Division | 3 | 2003 | 4564 | 0.110 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2017 | 839 | 0.110 |
Why?
|
Cell Line | 5 | 2017 | 15994 | 0.110 |
Why?
|
DNA Primers | 2 | 2015 | 2892 | 0.110 |
Why?
|
Australia | 1 | 2016 | 1167 | 0.110 |
Why?
|
Transition Temperature | 1 | 2012 | 36 | 0.110 |
Why?
|
Protein Transport | 2 | 2012 | 1988 | 0.110 |
Why?
|
Gene Knockout Techniques | 1 | 2015 | 808 | 0.110 |
Why?
|
RNA Interference | 1 | 2021 | 2890 | 0.110 |
Why?
|
Guanosine | 1 | 2012 | 61 | 0.110 |
Why?
|
Cytidine | 1 | 2012 | 68 | 0.110 |
Why?
|
Waist Circumference | 1 | 2016 | 917 | 0.100 |
Why?
|
Gene Knockdown Techniques | 2 | 2017 | 1655 | 0.100 |
Why?
|
Running | 1 | 2016 | 478 | 0.100 |
Why?
|
Dehydroepiandrosterone | 3 | 2002 | 252 | 0.100 |
Why?
|
Renal Insufficiency | 1 | 2017 | 802 | 0.100 |
Why?
|
History, 20th Century | 1 | 2019 | 2739 | 0.100 |
Why?
|
Oxazines | 1 | 2012 | 298 | 0.090 |
Why?
|
Community Mental Health Services | 1 | 2014 | 386 | 0.090 |
Why?
|
Receptors, Glucocorticoid | 1 | 2012 | 302 | 0.090 |
Why?
|
Rats, Inbred Strains | 5 | 1991 | 2191 | 0.090 |
Why?
|
Neoplasms | 1 | 2019 | 21596 | 0.090 |
Why?
|
Comorbidity | 5 | 2023 | 10372 | 0.090 |
Why?
|
Reproducibility of Results | 3 | 2017 | 19862 | 0.090 |
Why?
|
Kidney Medulla | 1 | 1990 | 182 | 0.090 |
Why?
|
Genetic Engineering | 1 | 2015 | 952 | 0.090 |
Why?
|
Exons | 1 | 2015 | 2431 | 0.090 |
Why?
|
HeLa Cells | 1 | 2015 | 3127 | 0.090 |
Why?
|
Glutathione | 2 | 2009 | 586 | 0.080 |
Why?
|
I-kappa B Proteins | 1 | 2009 | 225 | 0.080 |
Why?
|
Walking | 1 | 2016 | 1177 | 0.080 |
Why?
|
Kidney Tubules, Proximal | 2 | 1991 | 417 | 0.080 |
Why?
|
Adenosine Triphosphate | 2 | 2018 | 2024 | 0.080 |
Why?
|
bcl-2-Associated X Protein | 1 | 2009 | 295 | 0.080 |
Why?
|
Female | 20 | 2023 | 379592 | 0.080 |
Why?
|
Cells, Cultured | 9 | 2007 | 19223 | 0.080 |
Why?
|
Adenosine | 1 | 2012 | 823 | 0.070 |
Why?
|
Body Weight | 1 | 2018 | 4664 | 0.070 |
Why?
|
Rats, Sprague-Dawley | 3 | 2019 | 8300 | 0.070 |
Why?
|
Sodium | 2 | 1990 | 1627 | 0.070 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3564 | 0.070 |
Why?
|
3T3 Cells | 2 | 1999 | 1101 | 0.070 |
Why?
|
Recombinant Fusion Proteins | 1 | 2015 | 3770 | 0.070 |
Why?
|
COS Cells | 2 | 1999 | 1160 | 0.070 |
Why?
|
Conflict of Interest | 1 | 2011 | 542 | 0.070 |
Why?
|
Mice, Mutant Strains | 1 | 2009 | 1866 | 0.070 |
Why?
|
Enzyme Inhibitors | 4 | 2002 | 3800 | 0.070 |
Why?
|
Mice, Knockout | 2 | 2018 | 14554 | 0.070 |
Why?
|
Group Processes | 1 | 2007 | 225 | 0.070 |
Why?
|
Phosphorylation | 3 | 2005 | 8436 | 0.070 |
Why?
|
Disease Progression | 6 | 2017 | 13256 | 0.060 |
Why?
|
Streptozocin | 1 | 2005 | 193 | 0.060 |
Why?
|
Renal Circulation | 1 | 1986 | 333 | 0.060 |
Why?
|
Environmental Pollutants | 1 | 2014 | 1180 | 0.060 |
Why?
|
Hexosamines | 1 | 2004 | 42 | 0.060 |
Why?
|
Homozygote | 1 | 2009 | 1777 | 0.060 |
Why?
|
Patient Selection | 1 | 2017 | 4214 | 0.060 |
Why?
|
Protein Kinase C | 1 | 2009 | 1227 | 0.060 |
Why?
|
Uric Acid | 1 | 2010 | 760 | 0.060 |
Why?
|
Apoptosis | 4 | 2019 | 9715 | 0.060 |
Why?
|
Amyloid beta-Peptides | 1 | 1997 | 3574 | 0.060 |
Why?
|
Adult | 10 | 2017 | 213712 | 0.060 |
Why?
|
Cyclic AMP-Dependent Protein Kinase Type II | 1 | 2002 | 11 | 0.060 |
Why?
|
omega-N-Methylarginine | 1 | 2002 | 111 | 0.060 |
Why?
|
Cardiovascular Diseases | 2 | 2023 | 15108 | 0.060 |
Why?
|
RNA, Messenger | 2 | 2012 | 13029 | 0.060 |
Why?
|
Malate Dehydrogenase | 1 | 2002 | 41 | 0.060 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6483 | 0.060 |
Why?
|
Liver | 2 | 2023 | 7470 | 0.050 |
Why?
|
Heterozygote | 1 | 2009 | 2790 | 0.050 |
Why?
|
Nitric Oxide Synthase | 2 | 2002 | 916 | 0.050 |
Why?
|
Glutamate Decarboxylase | 1 | 2023 | 246 | 0.050 |
Why?
|
Angiotensin II | 1 | 1986 | 881 | 0.050 |
Why?
|
Mice, Inbred C57BL | 3 | 2019 | 21821 | 0.050 |
Why?
|
Young Adult | 4 | 2016 | 56350 | 0.050 |
Why?
|
Pterins | 1 | 2001 | 11 | 0.050 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2007 | 1213 | 0.050 |
Why?
|
Aldosterone | 1 | 2007 | 876 | 0.050 |
Why?
|
Risk Factors | 7 | 2017 | 72145 | 0.050 |
Why?
|
Kidney Function Tests | 2 | 2016 | 683 | 0.050 |
Why?
|
Middle Aged | 10 | 2017 | 213127 | 0.050 |
Why?
|
Nitric Oxide Synthase Type II | 1 | 2002 | 534 | 0.050 |
Why?
|
Base Sequence | 1 | 2012 | 12797 | 0.050 |
Why?
|
NF-kappa B | 1 | 2009 | 2500 | 0.050 |
Why?
|
Public Health | 1 | 2014 | 2594 | 0.050 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2000 | 220 | 0.050 |
Why?
|
Time Factors | 6 | 2017 | 40054 | 0.050 |
Why?
|
Endothelial Growth Factors | 1 | 2003 | 694 | 0.050 |
Why?
|
Program Development | 1 | 2007 | 1314 | 0.050 |
Why?
|
Health Care Costs | 1 | 2014 | 3203 | 0.050 |
Why?
|
Up-Regulation | 1 | 2009 | 4211 | 0.050 |
Why?
|
Lymphokines | 1 | 2003 | 949 | 0.040 |
Why?
|
Risk Assessment | 3 | 2017 | 23320 | 0.040 |
Why?
|
Interpersonal Relations | 1 | 2007 | 1423 | 0.040 |
Why?
|
Cell Line, Tumor | 2 | 2014 | 16665 | 0.040 |
Why?
|
Congenital Abnormalities | 1 | 2004 | 707 | 0.040 |
Why?
|
Hydrogen Peroxide | 2 | 2001 | 730 | 0.040 |
Why?
|
Placebos | 1 | 2003 | 1677 | 0.040 |
Why?
|
Carrier Proteins | 2 | 1990 | 5019 | 0.040 |
Why?
|
PC12 Cells | 1 | 1999 | 330 | 0.040 |
Why?
|
Ribosemonophosphates | 1 | 1998 | 6 | 0.040 |
Why?
|
Boston | 2 | 2012 | 9305 | 0.040 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2017 | 689 | 0.040 |
Why?
|
Body Mass Index | 1 | 2016 | 12695 | 0.040 |
Why?
|
Muscle, Smooth, Vascular | 1 | 1984 | 1504 | 0.040 |
Why?
|
Receptor, Bradykinin B1 | 1 | 2017 | 10 | 0.040 |
Why?
|
Receptor, Bradykinin B2 | 1 | 2017 | 24 | 0.040 |
Why?
|
Models, Biological | 2 | 2012 | 9581 | 0.040 |
Why?
|
Mice, Inbred DBA | 1 | 2019 | 642 | 0.040 |
Why?
|
Parathyroid Hormone | 1 | 1984 | 1801 | 0.040 |
Why?
|
Blotting, Western | 2 | 2017 | 5180 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 494 | 0.040 |
Why?
|
Neurons | 1 | 1997 | 9325 | 0.040 |
Why?
|
Learning | 1 | 2007 | 1705 | 0.040 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2019 | 290 | 0.040 |
Why?
|
Primary Health Care | 1 | 2014 | 4551 | 0.040 |
Why?
|
Health Behavior | 2 | 2023 | 2630 | 0.040 |
Why?
|
Kininogens | 1 | 2016 | 19 | 0.040 |
Why?
|
Diabetes Complications | 1 | 2004 | 1359 | 0.040 |
Why?
|
Basal Metabolism | 1 | 2018 | 168 | 0.040 |
Why?
|
Receptors, Bradykinin | 1 | 2016 | 19 | 0.040 |
Why?
|
Prevalence | 1 | 2014 | 15194 | 0.040 |
Why?
|
Cell Proliferation | 1 | 2012 | 10472 | 0.040 |
Why?
|
Blood | 1 | 1999 | 598 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2014 | 5133 | 0.040 |
Why?
|
Signal Transduction | 2 | 2002 | 23387 | 0.030 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2017 | 264 | 0.030 |
Why?
|
Neovascularization, Physiologic | 1 | 2003 | 1350 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2003 | 1675 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 24913 | 0.030 |
Why?
|
Mice, Inbred BALB C | 2 | 1999 | 6382 | 0.030 |
Why?
|
Autoantibodies | 1 | 2023 | 2036 | 0.030 |
Why?
|
Insulin | 1 | 2009 | 6575 | 0.030 |
Why?
|
1-Methyl-4-phenylpyridinium | 1 | 2014 | 30 | 0.030 |
Why?
|
Rotenone | 1 | 2014 | 43 | 0.030 |
Why?
|
Aged | 5 | 2023 | 162944 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2017 | 9941 | 0.030 |
Why?
|
Saponins | 1 | 1994 | 50 | 0.030 |
Why?
|
Oxidopamine | 1 | 2014 | 169 | 0.030 |
Why?
|
Kidney Glomerulus | 1 | 2017 | 697 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 2 | 1990 | 2552 | 0.030 |
Why?
|
Sleep Deprivation | 1 | 2020 | 830 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2002 | 10943 | 0.030 |
Why?
|
Analysis of Variance | 2 | 2007 | 6365 | 0.030 |
Why?
|
Herbicides | 1 | 2014 | 98 | 0.030 |
Why?
|
Physician-Patient Relations | 1 | 2007 | 3215 | 0.030 |
Why?
|
Tyrosine | 1 | 1998 | 1460 | 0.030 |
Why?
|
Type C Phospholipases | 1 | 1994 | 292 | 0.030 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1864 | 0.030 |
Why?
|
Organ Specificity | 1 | 2018 | 2003 | 0.030 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2014 | 276 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2017 | 2505 | 0.030 |
Why?
|
Cell Membrane Permeability | 1 | 1994 | 590 | 0.030 |
Why?
|
Peptide Fragments | 1 | 1984 | 5095 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2014 | 39004 | 0.030 |
Why?
|
Phosphogluconate Dehydrogenase | 1 | 1991 | 22 | 0.030 |
Why?
|
Fasting | 1 | 2018 | 1589 | 0.030 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 1994 | 437 | 0.030 |
Why?
|
Ionomycin | 1 | 1991 | 109 | 0.030 |
Why?
|
Guanine Nucleotides | 1 | 1991 | 68 | 0.030 |
Why?
|
Virulence Factors, Bordetella | 1 | 1991 | 156 | 0.030 |
Why?
|
Pertussis Toxin | 1 | 1991 | 178 | 0.020 |
Why?
|
Streptolysins | 1 | 1991 | 55 | 0.020 |
Why?
|
Inositol Phosphates | 1 | 1991 | 180 | 0.020 |
Why?
|
Cycloheximide | 1 | 1991 | 347 | 0.020 |
Why?
|
Brain | 1 | 2018 | 26343 | 0.020 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2016 | 1372 | 0.020 |
Why?
|
Cyclic GMP | 2 | 2003 | 408 | 0.020 |
Why?
|
Urinary Tract Infections | 1 | 2017 | 786 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2018 | 2203 | 0.020 |
Why?
|
Aging | 1 | 2009 | 8626 | 0.020 |
Why?
|
Ethylmaleimide | 1 | 1990 | 76 | 0.020 |
Why?
|
Ammonium Chloride | 1 | 1990 | 74 | 0.020 |
Why?
|
Pregnancy Complications | 1 | 2004 | 2861 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 1991 | 821 | 0.020 |
Why?
|
Amiloride | 1 | 1990 | 121 | 0.020 |
Why?
|
Proton-Translocating ATPases | 1 | 1990 | 116 | 0.020 |
Why?
|
Retrospective Studies | 2 | 2016 | 77098 | 0.020 |
Why?
|
Hypoglycemia | 1 | 2017 | 859 | 0.020 |
Why?
|
Self Report | 1 | 2020 | 3548 | 0.020 |
Why?
|
Sequence Deletion | 1 | 1994 | 1526 | 0.020 |
Why?
|
Nonlinear Dynamics | 1 | 2012 | 502 | 0.020 |
Why?
|
Fibrosis | 1 | 2016 | 2026 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 1986 | 9274 | 0.020 |
Why?
|
Isoenzymes | 1 | 1994 | 1725 | 0.020 |
Why?
|
Quality of Life | 1 | 2010 | 12730 | 0.020 |
Why?
|
Epithelium | 1 | 1994 | 1680 | 0.020 |
Why?
|
Dogs | 1 | 1994 | 3910 | 0.020 |
Why?
|
Serum Albumin | 1 | 2012 | 674 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3937 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2014 | 12344 | 0.020 |
Why?
|
Metabolomics | 1 | 2017 | 1467 | 0.020 |
Why?
|
Metabolome | 1 | 2014 | 881 | 0.020 |
Why?
|
Quality Improvement | 1 | 2023 | 3738 | 0.020 |
Why?
|
Dopamine | 1 | 2014 | 1589 | 0.020 |
Why?
|
Cyclic AMP Response Element Modulator | 1 | 2007 | 87 | 0.020 |
Why?
|
Protein Binding | 1 | 2019 | 9387 | 0.020 |
Why?
|
Electrophoretic Mobility Shift Assay | 1 | 2007 | 300 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 1994 | 1659 | 0.020 |
Why?
|
Microvilli | 1 | 1986 | 241 | 0.020 |
Why?
|
Natriuresis | 1 | 1986 | 124 | 0.020 |
Why?
|
Gene Expression | 1 | 1999 | 7790 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3510 | 0.020 |
Why?
|
Histocytochemistry | 1 | 1986 | 718 | 0.020 |
Why?
|
Blotting, Northern | 1 | 2007 | 1581 | 0.020 |
Why?
|
Sleep | 1 | 2020 | 4604 | 0.020 |
Why?
|
Pregnancy | 2 | 2023 | 29087 | 0.020 |
Why?
|
Protons | 1 | 1990 | 1126 | 0.020 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 1994 | 2938 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1994 | 6608 | 0.020 |
Why?
|
Glucosamine | 1 | 2004 | 132 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2014 | 3760 | 0.010 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2007 | 892 | 0.010 |
Why?
|
Mice, Inbred ICR | 1 | 2004 | 352 | 0.010 |
Why?
|
Adolescent | 3 | 2023 | 85649 | 0.010 |
Why?
|
Proteomics | 1 | 2017 | 3618 | 0.010 |
Why?
|
Xanthine | 1 | 2003 | 11 | 0.010 |
Why?
|
Spironolactone | 1 | 2007 | 382 | 0.010 |
Why?
|
Immunoblotting | 1 | 2007 | 1683 | 0.010 |
Why?
|
Phosphates | 1 | 1987 | 786 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2017 | 12017 | 0.010 |
Why?
|
DNA Replication | 1 | 1990 | 1397 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1986 | 2645 | 0.010 |
Why?
|
Xanthine Oxidase | 1 | 2003 | 64 | 0.010 |
Why?
|
Biological Transport | 1 | 1987 | 2119 | 0.010 |
Why?
|
Biological Availability | 1 | 2003 | 396 | 0.010 |
Why?
|
Kinetics | 1 | 1990 | 6474 | 0.010 |
Why?
|
Heart Failure | 1 | 1986 | 10856 | 0.010 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1994 | 2211 | 0.010 |
Why?
|
Linear Models | 1 | 2012 | 5948 | 0.010 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2003 | 772 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 2007 | 1224 | 0.010 |
Why?
|
Pteridines | 1 | 2001 | 45 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6534 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15056 | 0.010 |
Why?
|
Antigens | 1 | 1986 | 1462 | 0.010 |
Why?
|
Amino Acids | 1 | 1987 | 1727 | 0.010 |
Why?
|
Cell Separation | 1 | 1986 | 1749 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2017 | 57683 | 0.010 |
Why?
|
Vasodilation | 1 | 1984 | 944 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12242 | 0.010 |
Why?
|
Child | 2 | 2023 | 77478 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 12705 | 0.010 |
Why?
|
Embryonic Development | 1 | 2004 | 704 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2017 | 62966 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 1994 | 4249 | 0.010 |
Why?
|
Inflammation | 1 | 2016 | 10578 | 0.010 |
Why?
|
Survival Rate | 1 | 2011 | 12773 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2011 | 13921 | 0.010 |
Why?
|
Heart Ventricles | 1 | 1986 | 3801 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2003 | 3502 | 0.010 |
Why?
|
Prognosis | 1 | 2012 | 29010 | 0.010 |
Why?
|
Cell Movement | 1 | 2003 | 5212 | 0.010 |
Why?
|
Child, Preschool | 1 | 2012 | 40955 | 0.010 |
Why?
|
Prospective Studies | 1 | 2014 | 53187 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 1986 | 11690 | 0.000 |
Why?
|